What is a clinical trial?
Clinical trials are a set of procedures in medical research and drug development that are conducted to allow safety and efficacy data to be collected for health interventions (e.g., drugs, diagnostics, devices, therapy protocols). These trials can take place only after satisfactory information has been gathered on the quality of the non–clinical safety, and Health Authority/Ethics Committee approval is granted. These allow doctors to examine the benefits and risks of using these drugs. Clinical trials are designed to find safe treatments that work in people and new ways to improve health.
Why you should consider participating in a clinical trial?
In many different situations, clinical trials offer cutting edge treatment other wise not available to patients. A patient could benefit from his participation, since in many diseases, like dry macular degeneration, there is no other available treatment. Patients can also benefit since normally all procedures are cover by the pharmaceutical company or sponsor, and can have access to different modalities of treatment. Patient will contribute to enhance the future treatments. Will also benefit in the knowledge acquisition regarding a specific disease.
How patients are protected during the participation in a clinical trial?
Patients are protected by the Food and Drug Administration (FDA), The National Institute of Health (NIH) and Independent Review Boards. These identities oversee all research to protect the rights and maintain welfare of all study participants.
If you will like more information please visit the following websites:
Current Protocols Enrolling at our Practice:
- Regeneron VGFT-e-1411.3 Pamorama for Diabetic Retinopathy
- DRCR.net Protocol W for Diabetic Retinopathy
- Allergan 150998-006 Sequoia for ARMD- Wet
- Roche Chroma GX29176 for ARMD – Dry
- Roche GX 30191 OMASPECT- For – ARMD Dry
- Allergan Acacia Study for Diabetic Macular Edema
If you have any questions or would like to enroll in any of our clinical trials please call Noel Pereda or Maria Gutierrez at our research department at 954-635-2861.